financetom
Business
financetom
/
Business
/
Neptune Reports Purchase of 26,964 Solana; Up 2.8%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Neptune Reports Purchase of 26,964 Solana; Up 2.8%
Mar 27, 2024 11:13 AM

01:53 PM EDT, 03/27/2024 (MT Newswires) -- Neptune Digital Assets Corp. ( NPPTF ) said Wednesday that it has bought 26,964 Solana tokens, a proof-of-stake blockchain protocol.

The company said it has negotiated a strategic purchase of 26,964 Solana at US$64 per SOL token, reflecting a 67% discount to the current market value of US$192 per SOL.

Neptune's new Solana balance is now 31,181 tokens.

With Solana's PoS mechanism, Neptune expects to generate about a 7.5% annual yield. The Solana tokens acquired by Neptune will be locked and staked.

The company said 80% will be released linearly on a monthly basis until January 2028; and 20% will be released in March 2025.

The company's stock was up 2.8% on last look on Wednesday.

Price: 0.37, Change: +0.01, Percent Change: +2.78

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,142,536, According to a Recent SEC Filing
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,142,536, According to a Recent SEC Filing
May 29, 2024
04:12 PM EDT, 05/29/2024 (MT Newswires) -- Michael S Brown, Director, on May 28, 2024, sold 1,172 shares in Regeneron Pharmaceuticals ( REGN ) for $1,142,536. Following the Form 4 filing with the SEC, Brown has control over a total of 12,544 shares of the company, with 1,382 shares held directly and 11,162 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/872589/000110465924066045/xslF345X03/tm2414958-1_4seq1.xml ...
Vertex Pharmaceuticals Insider Sold Shares Worth $715,205, According to a Recent SEC Filing
Vertex Pharmaceuticals Insider Sold Shares Worth $715,205, According to a Recent SEC Filing
May 29, 2024
04:13 PM EDT, 05/29/2024 (MT Newswires) -- Reshma Kewalramani, Director, CEO & President, on May 24, 2024, sold 1,565 shares in Vertex Pharmaceuticals ( VRTX ) for $715,205. Following the Form 4 filing with the SEC, Kewalramani has control over a total of 121,374 shares of the company, with 121,374 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/875320/000087532024000160/xslF345X03/wk-form4_1717013304.xml ...
McDonald's top US exec denounces viral reports of runaway prices
McDonald's top US exec denounces viral reports of runaway prices
May 29, 2024
(Reuters) - McDonald's top U.S. executive denounced viral reports of runaway Big Mac prices as painting an inaccurate picture of the company, which has seen its profits surge by roughly a third since 2019 and is now preparing to roll out $5 combo meals. I can tell you that it frustrates and worries me, and many of our franchisees, when...
S&P revises TD Bank's outlook to 'negative' on risk management weakness
S&P revises TD Bank's outlook to 'negative' on risk management weakness
May 29, 2024
May 29 (Reuters) - S&P Global ( SPGI ) said on Wednesday it had revised the rating outlook on Toronto-Dominion Bank ( MLWIQXX ) to negative from stable, citing weakness in the bank's risk management and controls. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved